Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

13.03
+0.02000.15%
Post-market: 12.95-0.0800-0.61%16:10 EDT
Volume:361.18K
Turnover:4.70M
Market Cap:1.37B
PE:-8.41
High:13.22
Open:13.11
Low:12.86
Close:13.01
Loading ...
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Major Issues Report

Form 8-K - Current report
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]